Sign inJoin waitlistJoin the waitlist

Sunandana Chandra

Associate Professor · Feinberg School of Medicine

Credentials: · · · ·

History

Feinberg School of Medicine
Present

NYU Grossman School of Medicine
Until 2014
Case Western Reserve University/University Hospitals Cleveland Medical Center
Until 2011
Michigan State University College of Human Medicine
2008

Research

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Systematic review or meta-analysis · JAMA Oncology · 2018 · 2,273 citations
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
New England Journal of Medicine · 2023 · 739 citations
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134
Journal of Clinical Oncology · 2023 · 392 citations

Jeffrey Sosman
27 papers
Douglas Johnson
14 papers
FG
Francis Giles
11 papers
Jacob Choi
11 papers · 6 as a fellow
Shailender Bhatia
11 papers
Young Chae
11 papers
ZE
Zeynep Eroglu
11 papers
Benedito Carneiro
10 papers
NK
Nikhil Khushalani
10 papers
Ann Silk
8 papers
CB
Christopher Barker
8 papers
JK
Jason Kaplan
8 papers

Clinical trials

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
Site PI · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2024–2027
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Site PI · Recruiting · Phase 3
Replimune, Inc.
2024–2031